AKT1 and Histiocytosis: Other signaling pathways for which we have specific inhibitors (AKT/mTOR, ALK, and CSF1R) (25, 26) now pave the way for targeted therapies rather than conventional chemotherapy regimens in adult clonal histiocytosis.